Cyclic Vomiting Syndrome Clinical Trials

Find Cyclic Vomiting Syndrome Clinical Trials Near You

Auricular Neurostimulation for Children With Cyclic Vomiting Syndrome: A Randomized, Sham Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Cyclic vomiting syndrome (CVS) is a fairly common disorder characterized by relentless episodes of vomiting followed by return to baseline health.The majority of children with CVS have concurrent severe abdominal pain and migraine-features, causing significant disability during the attacks. There are very few non-drug treatment options for CVS. Many patients are treated with antidepressants that are often ineffective and may cause serious side effects. Emergency room visits and hospitalizations for patients with CVS is extremely high and the syndrome has an immense impact on quality of life. Safe and effective, non-pharmacological therapies for children with CVS are greatly needed. Nausea, vomiting and gastrointestinal pain is modulated by the vagus nerve, an important regulator of the autonomic nervous system. The vagus communicates signals between the gastrointestinal tract and the central nervous system. Many studies indicate that vagal nerve stimulation is effective for various pain and vomiting conditions. Recent studies show that vagus nerve signaling is impaired in children with CVS. Researchers have demonstrated safety and efficacy of auricular percutaneous electrical nerve field stimulation (PENFS) targeting the vagus nerve in a small study of children with CVS. The aim of the current study is to investigate the effects of non-invasive PENFS on CVS episode frequency, duration and severity compared to a sham device in a randomized clinical trial.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Maximum Age: 18
Healthy Volunteers: f
View:

• Episodic vomiting that meet criteria for CVS based on the 2025 NASPGHAN guidelines for diagnosis of pediatric CVS

• English-speaking

• Lack of other explanation for vomiting

• Intact external ear that is free of infection or severe dermatological conditions

• Stable stable vital signs for their respective age

• No currently implanted electrical device

• Family able to accurately describe symptoms and number of vomiting episodes

• At least 2 vomiting episodes during the 6 months prior to enrollment

Locations
United States
Wisconsin
Children's Wisconsin
RECRUITING
Milwaukee
Contact Information
Primary
Rachel Unteutsch, BS
runteutsch@mcw.edu
4142664844
Time Frame
Start Date: 2026-02-11
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 120
Treatments
Experimental: Active Percutaneous Electrical Nerve Field Stimulation (PENFS)
Active PENFS device x 5 consecutive weeks
Sham_comparator: Sham Percutaneous Electrical Nerve Field Stimulation (PENFS)
Sham PENFS device x 5 consecutive weeks
Related Therapeutic Areas
Sponsors
Leads: Medical College of Wisconsin

This content was sourced from clinicaltrials.gov

Similar Clinical Trials